Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuo Shimada

Showing results (661-670 of 672) with videos related to

Pageof 68
Sort By:
Liver Cancer|July 9, 2021
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 UpdateMasatoshi Kudo, Yusuke Kawamura, Kiyoshi Hasegawa, et al.
Journal of Gastroenterology|August 24, 2016
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trialMasatoshi Kudo, Etsuro Hatano, Shinichi Ohkawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita, et al.
Cancer Science|October 27, 2016
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC studyNobuaki Suzuki, Shoichi Hazama, Haruo Iguchi, et al.
Hepatology (Baltimore, Md.)|August 15, 2012
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinomaTokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 1, 2017
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancerYoshitaro Shindo, Shoichi Hazama, Nobuaki Suzuki, et al.
Surgery Today|February 25, 2017
Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trialYoshihiko Maehara, Ken Shirabe, Shunji Kohnoe, et al.
Surgery Today|September 29, 2017
Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trialYoshihiko Maehara, Ken Shirabe, Shunji Kohnoe, et al.
International Journal of Clinical Oncology|March 24, 2023
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro FujiiYoshihiko Maehara, Eiji Oki, Mitsuhiko Ota, et al.
Surgery Today|December 3, 2024
Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in JapanYasuhiro Miyazaki, Masayuki Ohta, Seiichi Kitahama, et al.
Pageof 68

Showing results (661-670 of 672) with videos related to

Sort By:
Pageof 68
Liver Cancer|July 9, 2021
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 UpdateMasatoshi Kudo, Yusuke Kawamura, Kiyoshi Hasegawa, et al.
Journal of Gastroenterology|August 24, 2016
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trialMasatoshi Kudo, Etsuro Hatano, Shinichi Ohkawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)Kiyoshi Hasegawa, Nobuyuki Takemura, Tatsuya Yamashita, et al.
Cancer Science|October 27, 2016
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC studyNobuaki Suzuki, Shoichi Hazama, Haruo Iguchi, et al.
Hepatology (Baltimore, Md.)|August 15, 2012
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinomaTokuzo Arao, Kazuomi Ueshima, Kazuko Matsumoto, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 1, 2017
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancerYoshitaro Shindo, Shoichi Hazama, Nobuaki Suzuki, et al.
Surgery Today|February 25, 2017
Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trialYoshihiko Maehara, Ken Shirabe, Shunji Kohnoe, et al.
Surgery Today|September 29, 2017
Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trialYoshihiko Maehara, Ken Shirabe, Shunji Kohnoe, et al.
International Journal of Clinical Oncology|March 24, 2023
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro FujiiYoshihiko Maehara, Eiji Oki, Mitsuhiko Ota, et al.
Surgery Today|December 3, 2024
Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in JapanYasuhiro Miyazaki, Masayuki Ohta, Seiichi Kitahama, et al.
Pageof 68